EVAX

NASD Evaxion A/S Sponsored ADR
Oct 21, 2026 · 6:04 PM ET LAST TRADE Market Closed

$3.96 ↑ +0.25 (+6.74%) Trading Up from the previous close of $3.71, $0.54 below the day’s high of $4.50

YTD change
-16.98%
vs 20-day SMA
+25.30%
vs 200-day SMA
+10.83%

Price ranges

Previous day
$3.22 $4.12
open $3.30 close $4.05
+$0.75 (+22.73%)
Today
$3.65 $4.50
open $4.16 now $3.96
-$0.20 (-4.81%)
Past week
$2.75 $4.12
from $2.76 now $3.96
+$1.20 (+43.48%)
Past month
$2.72 $4.12
from $3.27 now $3.96
+$0.69 (+21.10%)
This year
$2.72 $5.48
from $4.77 now $3.96
-$0.81 (-16.98%)

Price & Performance

-0.45 (-10.00%) / 6M

$2.62$3.32$4.01$4.71Apr 21Jul 22Oct 20

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good
  • The stock is 99.7% away from all-time highs of $1,252.00
  • EVAX is down 17% since the beginning of the year
  • EVAX is down 39% over the past 12 months
  • EVAX is up 21% over the past 1 month
  • 1% of all EVAX investors are betting against EVAX

EVAX reads very good: price sits above both the 20- and 200-day averages, the 12-month move is -38.0%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.01
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Enterprise value $26.9M
Beta 0.03

Balance sheet & scale

IncomeN/A
Revenue$7.5M
Cash$14.0M
Debt$7.1K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $33.0M

Evaxion AS engages in the discovery and development of immunotherapies for cancer and infectious diseases. Its technologies include the immuno-oncology platform PIONEER, the bacterial disease platform EDEN, the viral disease platform RAVEN, and the proprietary AI platform technology ObsERV. The company was founded by Niels Iversen Møller and Andreas Holm Mattsson on August 11, 2008 and is headquartered in Hoersholm, Denmark.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $438.94 +3.29%
MRNA Moderna, Inc. $242.08 +6.69%
RVMD Revolution Medicines, Inc. $196.55 +7.91%
ROIV Roivant Sciences Ltd. $34.92 +0.63%
BNTX BioNTech SE Sponsored ADR $91.17 +2.20%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.